📰 Human Use News
Page 113 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
September 20, 2022
A regulatory filing with the US Food and Drug Administration for approval in adolescents is in progress, according to the manufacturer.
September 20, 2022
The EC approval is based on positive 18-month results from the HELIOS-A Phase 3 study, where AMVUTTRA significantly improved the signs and symptoms of hATTR amyloidosis, with more than 50 percent of patients experiencing halting or reversal of their polyneuropathy manifestations.
September 20, 2022
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis - News - PharmaTimes
September 19, 2022
- CHMP positive opinion is based on results from three Phase 3 studies: two for induction and one for maintenance1,2 - Crohns disease is a chronic, systemic...
September 19, 2022
Visiongain has published a new report entitled Gene Therapy R&D 2022-2032. It includes profiles of Gene Therapy R&D and Forecasts Market Segment by...
September 17, 2022
Wall Street ended a terrible week with further declines.
September 17, 2022
RSV prevention includes vaccines candidates and antibody treatment
September 16, 2022
Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY Original/Omicron BA.4-5 and COMIRNATY Original/Omicron BA.1 bivalent
September 16, 2022
16.09.2022 - CHMP adopts positive opinion for Mycapssa for the treatment of Acromegaly Positive opinion based on MPOWERED Phase 3 trial DUBLIN, Ireland, and Boston MA, September 16, 2022, Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical ... Seite 1
September 16, 2022
Approval decision expected in 4Q 2022 ADC Therapeutics SA (NYSE: ADCT) and Swedish Orphan Biovitrum AB (Sobi) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European